Alfayez M, Kantarjian H, Ravandi F, Konopleva M, Jabbour E, Garcia-Manero G, Kadia T, Borthakur G, DiNardo C, Estrov Z, Pemmaraju N, Pierce S, Yilmaz M, Short N, Takahashi K, Assi R, Andreeff M , Cortes JE, Daver N
Here, we integrated multiplatform metabolomics and proteomics with precise clinical phenotyping to delineate molecular signatures in plasma across different PD subtypes
Although a great effort has been made to develop organ-specific nucleic acid delivery systems, the design of active-targeted carriers with high quality, good clinical translation, and large-scale manufacturing capacity is still challenging
I've seen too many people get caught up in flashy marketing without considering what really matters: medical expertise, safety protocols, and personalized care